MAPK3 and neoplasm: Furthermore, patients co-expressing high levels of POSTN and p-ERK1/2 exhibited a more aggressive tumor phenotype (Chen et al., 2019): Compared with patients with low expression of these two molecules, they showed greater depth of tumor invasion, higher rates of lymph node metastasis, and more distant metastases.